Microbiota-derived 3-Methyl-L-histidine mediates the proatherogenic effect of high chicken protein diet

Abstract

Diet rich in chicken protein has gained a widespread popularity for its profound effect on weight loss and glycemic control; however, its long-term effect on cardiovascular health and the underlying mechanisms remains obscure. Here, we demonstrated that higher intake of chicken protein was an independent risk factor for sub-clinical atherosclerosis. Adherence to high chicken protein diet (HCD) alleviated excessive weight gain and glycemic control regardless of the presence of gut microbiota in apolipoprotein E–deficient mice. In contrast, long-term HCD administration enhanced intestinal cholesterol absorption and accelerated atherosclerotic plaque formation in a gut microbiota-dependent manner. Integrative analysis of 16S rDNA sequencing and metabolomics profiling identified 3-Methyl-L-histidine (3-MH), resulting from an enrichment of Lachnospiraceae, as the key microbial effector to the atherogenic effect of HCD. Mechanistically, 3-MH facilitated the binding of hepatocyte nuclear factor 1A (HNF1A) to the promoter of NPC1-like intracellular cholesterol transporter 1 (NPC1L1), whereas inhibition of HNF1A–NPC1L1 axis abolished the atherogenic effect of 3-MH. Our findings uncovered a novel link between microbiota-derived 3-MH and disturbed cholesterol homeostasis, which ultimately accelerated atherosclerosis, and argued against the recommendation of HCD as weight loss regimens considering its adverse role in vascular health.

Keywords

3-Methyl-L-hisitidine / atherosclerosis / gut microbiota / high chicken protein diet / intestinal cholesterol absorption

References

[1] Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258): 1204-1222.

[2] Nedkoff L, Briffa T, Zemedikun D et al. Global trends in atherosclerotic cardiovascular disease. Clin Ther. 2023; 45(11): 1087-1091.

[3] Arnett DK, Blumenthal RS, Albert MA et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019; 140(11): e596-e646.

[4] Manninen AH. High-protein weight loss diets and purported adverse effects: where is the evidence? J Int Soc Sports Nutr. 2004; 1(1): 45.

[5] Melanson K, Gootman J, Myrdal A et al. Weight loss and total lipid profile changes in overweight women consuming beef or chicken as the primary protein source. Nutrition. 2003; 19(5): 409-414.

[6] He K, Song Y, Daviglus ML et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation. 2004; 109(22): 2705-2711.

[7] Bergeron N, Chiu S, Williams PT et al. Effects of red meat, white meat, and nonmeat protein sources on atherogenic lipoprotein measures in the context of low compared with high saturated fat intake: a randomized controlled trial. Am J Clin Nutr. 2019; 110(1): 24-33.

[8] Attaye I, Pinto-Sietsma SJ, Herrema H et al. A crucial role for diet in the relationship between gut microbiota and cardiometabolic disease. Annu Rev Med. 2020;27(71):149-161.

[9] Murphy EA, Velazquez KT, Herbert KM. Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk. Curr Opin Clin Nutr Metab Care. 2015; 18(5): 515-520.

[10] Roberts AB, Gu X, Buffa JA et al. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med. 2018; 24(9): 1407-1417.

[11] Koeth RA, Wang Z, Levison BS et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013; 19(5): 576-585.

[12] Merra G, Noce A, Marrone G et al. Influence of mediterranean diet on human gut microbiota. Nutrients. 2020; 13(1): 7.

[13] Aleixandre A, Miguel M. Dietary fiber and blood pressure control. Food Funct. 2016; 7(4): 1864-1871.

[14] Navas-Carretero S, Cuervo M, Abete I et al. Frequent consumption of selenium-enriched chicken meat by adults causes weight loss and maintains their antioxidant status. Biol Trace Elem Res. 2011; 143(1): 8-19.

[15] Zhang X, Sergin I, Evans TD et al. High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy. Nat Metab. 2020; 2(1): 110-125.

[16] Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013; 40(1): 195-211.

[17] Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020; 21(4): 225-245.

[18] Wu L, Tang Z, Chen H et al. Mutual interaction between gut microbiota and protein/amino acid metabolism for host mucosal immunity and health. Anim Nutr. 2021; 7(1): 11-16.

[19] Zheng R, Wan C, Mei S et al. Cistrome data browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 2019; 47(D1): D729-D735.

[20] Keenan AB, Torre D, Lachmann A et al. ChEA3: transcription factor enrichment analysis by orthogonal omics integration. Nucleic Acids Res. 2019; 47(W1): W212-W224.

[21] Pesta DH, Samuel VT. A high-protein diet for reducing body fat: mechanisms and possible caveats. Nutr Metab (Lond). 2014; 11(1): 53.

[22] Becerra-Tomas N, Babio N, Martinez-Gonzalez MA et al. Replacing red meat and processed red meat for white meat, fish, legumes or eggs is associated with lower risk of incidence of metabolic syndrome. Clin Nutr. 2016; 35(6): 1442-1449.

[23] Zhubi-Bakija F, Bajraktari G, Bytyci I et al. The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: a position paper from the International Lipid Expert Panel (ILEP). Clin Nutr. 2021; 40(1): 255-276.

[24] Pickering RT, Yuan M, Singer MR et al. Protein intake is associated with lower risk of type 2 diabetes in the Framingham offspring study. Circulation. 2020; 141(Suppl_1):AMP55.

[25] Ostgren CJ, Sundstrom J, Svennblad B et al. Associations of HbA1c and educational level with risk of cardiovascular events in 32, 871 drug-treated patients with type 2 diabetes: a cohort study in primary care. Diabet Med. 2013; 30(5): e170-e177.

[26] Gerstein HC, Miller ME, Byington RP et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24): 2545-2559.

[27] Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360(2): 129-139.

[28] Moschen AR, Wieser V, Tilg H. Dietary factors: major regulators of the gut’s microbiota. Gut Liver. 2012; 6(4): 411-416.

[29] Liu Y, Yang K, Jia Y et al. Gut microbiome alterations in high-fat-diet-fed mice are associated with antibiotic tolerance. Nat Microbiol. 2021; 6(7): 874-884.

[30] Roth E, Zoch G, Schulz F et al. Amino acid concentrations in plasma and skeletal muscle of patients with acute hemorrhagic necrotizing pancreatitis. Clin Chem. 1985; 31(8): 1305-1309.

[31] Schutkowski A, Konig B, Kluge H et al. Metabolic footprint and intestinal microbial changes in response to dietary proteins in a pig model. J Nutr Biochem. 2019; 67: 149–160.

[32] Mohan C, Bessman SP. In vitro protein degradation measured by differential loss of labeled methionine and 3-methylhistidine: the effect of Insulin. Anal Biochem. 1981; 118(1): 17-22.

[33] Kouzu H, Katano S, Yano T et al. Plasma amino acid profiling improves predictive accuracy of adverse events in patients with heart failure. ESC Heart Fail. 2021; 8(6): 5045-5056.

[34] Nemet I, Saha PP, Gupta N et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell. 2020; 180(5): 862-877 e822.

[35] Siri-Tarino PW, Krauss RM. Diet, lipids, and cardiovascular disease. Curr Opin Lipidol. 2016; 27(4): 323-328.

[36] Ma J, Zheng Y, Tang W et al. Dietary polyphenols in lipid metabolism: a role of gut microbiome. Anim Nutr. 2020; 6(4): 404-409.

[37] Sudhop T, von Bergmann K. Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia. Drugs. 2002; 62(16): 2333-2347.

[38] Pramfalk C, Jiang ZY, Cai Q et al. HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver. J Lipid Res. 2010; 51(6): 1354-1362.

[39] Liu H, Liu J, Liu Z et al. Lycopene reduces cholesterol absorption and prevents atherosclerosis in ApoE(-/-) mice by downregulating HNF-1alpha and NPC1L1 expression. J Agric Food Chem. 2021; 69(35): 10114-10120.

[40] Parini P, Melhuish TA, Wotton D et al. Overexpression of transforming growth factor beta induced factor homeobox 1 represses NPC1L1 and lowers markers of intestinal cholesterol absorption. Atherosclerosis. 2018; 275: 246-255.

[41] Zhang J, Hayden K, Jackson R et al. Association of red and processed meat consumption with cardiovascular morbidity and mortality in participants with and without obesity: a prospective cohort study. Clin Nutr. 2021; 40(5): 3643-3649.

[42] Chow S-C, Wang H, Shao J. Sample Size Calculations in Clinical Research. Chapman and Hall/CRC; 2007.

[43] Berben L, Sereika SM, Engberg S. Effect size estimation: methods and examples. Int J Nurs Stud. 2012; 49(8): 1039-1047.

[44] Fluhr L, Mor U, Kolodziejczyk AA et al. Gut microbiota modulates weight gain in mice after discontinued smoke exposure. Nature. 2021; 600(7890): 713-719.

[45] Chen X, Zhang F, Gong Q et al. Hepatic ATF6 increases fatty acid oxidation to attenuate hepatic steatosis in mice through peroxisome proliferator-activated receptor alpha. Diabetes. 2016; 65(7): 1904-1915.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.